We are a global, innovation-driven biopharmaceutical business with a focus on research, development and commercialization of prescription medicines.
Our goal is to make a meaningful difference to patient health through great medicines.
We focus on the research, development, manufacture and marketing of prescription medicines for stomach / intestines, heart / vascular, neuroscience, respiratory and inflammation, oncology and infectious diseases.
We know that we alone can not get the drugs that people really need. We
work closely with all our stakeholders to understand their needs and challenges.
Our medicines are marketed in Sweden by AstraZeneca Nordic which has its head office in Sweden and local offices in Denmark, Norway and Finland. Click for details>>
Sweden
![4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,sodium salt, hydrate (1:1:1), (2S,5R,6R)-(7081-44-9)](http://file1.lookchem.com/cas/reactions/2021/09/28/14633608.png)